Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Utrogestan × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Premature Birth 1 Polycystic Ovary Syndrome 1 Obesity 1 Neoplasm Metastasis 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Exercise 22 Metformin 18 Tirzepatide 8 Diet 8 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 7 Resistance Training 6 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Tamoxifen 3 Standard of Care 3 Observation 3 Naltrexone 3 Dexamethasone 3 Bupropion 3 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04175002 2019-11-22

Endometrial Heparin-binding Epidermal Growth Factor Expression

National University of Malaysia

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡